Clinical Trials List
Protocol NumberPK NDA-T375-1502
2016-02-01 - 2017-01-31
Phase I
Terminated1
ICD-10F90.1
Attention-deficit hyperactivity disorder, predominantly hyperactive type
ICD-10F90.2
Attention-deficit hyperactivity disorder, combined type
ICD-10F90.8
Attention-deficit hyperactivity disorder, other type
ICD-10F90.9
Attention-deficit hyperactivity disorder, unspecified type
ICD-9314.01
Attention deficit disorder, with hyperactivity
-
Trial Applicant
Orient PHARMA Co., Ltd.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
16 participants
